Expression of serum/glucocorticoid-inducible kinase (Sgk), one member of an inducible serine/threonine kinase family, is induced by FSH/cAMP in rat granulosa cells cultured in defined medium. The FSH-stimulated pattern of sgk expression is biphasic, and transcriptional activation of the sgk gene depends on an intact Sp1/Sp3 binding site within the proximal promoter. To determine whether sgk was expressed in a hormone-dependent and physiologically relevant manner in vivo, the cellular levels of sgk messenger RNA (mRNA) and protein as well as the subcellular localization of this kinase were analyzed in ovaries containing follicles and corpora lutea at specific stages of differentiation. To stimulate follicular development and luteinization, hypophysectomized (H) rats were treated with estradiol (E; HE) and FSH (FSH; HEF) followed by hCG (hCG; HEF/hCG). To analyze Sgk in functional corpora lutea, PRL was administered to HEF/hCG rats, or ovaries of pregnant rats were obtained on day 7, 15, or 22 of gestation. In situ hybridization indicated that sgk mRNA was low/undetectable in granulosa cells of H and HE rats. An acute injection (iv) of FSH to HE rats rapidly increased sgk mRNA at 2 and 8 h. Sgk mRNA was also elevated in granulosa cells of preovulatory follicles of HEF rats and in luteal cells of HEF/hCG and pregnant rats. Northern blots and Western blots confirmed the in situ hybridization data, indicating that the amount and cellular localization Sgk protein were related to that of sgk mRNA. When the subcellular localization of this kinase was analyzed by immunohistochemistry, Sgk protein was nuclear in granulosa cells and some thecal cells of large preovulatory follicles. In contrast, Sgk protein was cytoplasmic in luteal cells as well as some cells within the stromal compartment. Intense immunostaining was also observed in oocytes present in primordial follicles, but not in growing follicles. Collectively, these results show that FSH and LH stimulate marked increases in the cellular content of Sgk, as well as dramatic changes in the subcellular distribution of this kinase. The specific nuclear vs. cytoplasmic compartmentalization of Sgk in granulosa cells and luteal cells, respectively, indicates that Sgk controls distinct functions in proliferative vs. terminally differentiated granulosa cells. (Endocrinology 141: [385][386][387][388][389][390][391][392][393][394][395] 2000) O VARIAN FOLLICULAR development, ovulation, and luteinization depend on sequential as well as synergistic interactions of cellular signaling cascades (1). Key regulators of these activities are FSH and LH, which bind to their cognate receptors, activate adenylyl cyclase, and thereby lead to the activation of cAMP-dependent protein kinase, A-kinase (1). A-kinase not only regulates its own pathway by controlling levels of its regulatory (RII␤) subunits (2), LH receptors (3), and the phosphorylation of transcription factors such as cAMP response element-binding protein (4, 5), but it is also known to regulate other cellular signaling pathways that control cell proliferation and differentiation. These include the cyclin-dependent kinases (cdks) that control cell cycle progression through mitosis and G 1 (6 -8). In ovarian follicles, activators of cdk4/6 and cdk2, such as cyclin D2 and cyclin E, as well as the inhibitors of these cdks, such as p21 CIP1 and p27 KIP1 , are regulated by A-kinase at specific stages of proliferation and differentiation (Refs. 9 -11 and references therein). FSH has also been shown to regulate mitogen-activated protein kinases (12, 13), whereas LH regulates the expression of PRL receptors (14 -16), which, in response to the cytokine, activates the Jak/Stat signaling pathway in rat luteal cells (17) (18) (19) . In addition, several members of a family of novel, serine/threonine kinases that are associated with proliferation have been shown to be expressed in the ovary (20 -25). Members of this kinase family, serum/glucocorticoid-inducible protein kinase, sgk (20); serum-inducible kinase, snk (23); fibroblast growth factor inducible kinase, fnk (24); and proliferation-related kinase, prk (25), have been distinguished by immediate early transcriptional inducibility. Unlike other kinases, such as A-kinase, that are constitutively present in cells and are activated by posttranslational mechanisms such as phosphorylation or ligand binding, these novel kinases are rapidly trans-activated in response to specific hormonal and environmental stimuli. Of particular interest is the observation that one of these kinases, Sgk, has not only been detected in proliferating cells but has also been observed in differentiating cells (20 -22), suggestive of more diverse functions for this particular member of the inducible kinase family.
jection (iv) of FSH to HE rats rapidly increased sgk mRNA at 2 and 8 h. Sgk mRNA was also elevated in granulosa cells of preovulatory follicles of HEF rats and in luteal cells of HEF/hCG and pregnant rats. Northern blots and Western blots confirmed the in situ hybridization data, indicating that the amount and cellular localization Sgk protein were related to that of sgk mRNA. When the subcellular localization of this kinase was analyzed by immunohistochemistry, Sgk protein was nuclear in granulosa cells and some thecal cells of large preovulatory follicles. In contrast, Sgk protein was cytoplasmic in luteal cells as well as some cells within the stromal compartment. Intense immunostaining was also observed in oocytes present in primordial follicles, but not in growing follicles. Collectively, these results show that FSH and LH stimulate marked increases in the cellular content of Sgk, as well as dramatic changes in the subcellular distribution of this kinase. The specific nuclear vs. cytoplasmic compartmentalization of Sgk in granulosa cells and luteal cells, respectively, indicates that Sgk controls distinct functions in proliferative vs. terminally differentiated granulosa cells. (Endocrinology 141: [385] [386] [387] [388] [389] [390] [391] [392] [393] [394] [395] 2000) O VARIAN FOLLICULAR development, ovulation, and luteinization depend on sequential as well as synergistic interactions of cellular signaling cascades (1) . Key regulators of these activities are FSH and LH, which bind to their cognate receptors, activate adenylyl cyclase, and thereby lead to the activation of cAMP-dependent protein kinase, A-kinase (1) . A-kinase not only regulates its own pathway by controlling levels of its regulatory (RII␤) subunits (2) , LH receptors (3) , and the phosphorylation of transcription factors such as cAMP response element-binding protein (4, 5) , but it is also known to regulate other cellular signaling pathways that control cell proliferation and differentiation. These include the cyclin-dependent kinases (cdks) that control cell cycle progression through mitosis and G 1 (6 -8) . In ovarian follicles, activators of cdk4/6 and cdk2, such as cyclin D2 and cyclin E, as well as the inhibitors of these cdks, such as p21 CIP1 and p27 KIP1 , are regulated by A-kinase at specific stages of proliferation and differentiation (Refs. 9 -11 and references therein). FSH has also been shown to regulate mitogen-activated protein kinases (12, 13) , whereas LH regulates the expression of PRL receptors (14 -16) , which, in response to the cytokine, activates the Jak/Stat signaling pathway in rat luteal cells (17) (18) (19) . In addition, several members of a family of novel, serine/threonine kinases that are associated with proliferation have been shown to be expressed in the ovary (20 -25) . Members of this kinase family, serum/glucocorticoid-inducible protein kinase, sgk (20) ; serum-inducible kinase, snk (23) ; fibroblast growth factor inducible kinase, fnk (24) ; and proliferation-related kinase, prk (25) , have been distinguished by immediate early transcriptional inducibility. Unlike other kinases, such as A-kinase, that are constitutively present in cells and are activated by posttranslational mechanisms such as phosphorylation or ligand binding, these novel kinases are rapidly trans-activated in response to specific hormonal and environmental stimuli. Of particular interest is the observation that one of these kinases, Sgk, has not only been detected in proliferating cells but has also been observed in differentiating cells (20 -22) , suggestive of more diverse functions for this particular member of the inducible kinase family.
Since the initial report that sgk transcripts were present in RNA prepared from whole rat ovary (20) , we have conducted additional experiments to determine whether sgk expression was localized to specific ovarian cell types and whether it was regulated by specific hormones during follicular or luteal development. Using well characterized cultures of rat granulosa cells, we have shown that sgk is induced in a biphasic pattern by FSH or forskolin, agonists that increase intracellular cAMP (26) . In response to these agonists, sgk messenger RNA (mRNA) and protein increase rapidly by 2 h, decrease at 6 h, and then reach maximal levels at 48 h (26) . This pattern of expression closely mirrors nuclear levels of the A-kinase C-subunit (4, 27) , indicating that transcriptional regulation of the sgk gene is mediated in part by A-kinase. Using deletional and site-specific mutants of the sgk promoter, we have shown that the A-kinase-inducible expression of the sgk gene in ovarian cells is dependent in part on an Sp1/Sp3 binding region within the proximal promoter (26) .
More recently, we have determined, using affinity-purified antibodies, that the subcellular localization of Sgk protein is dependent on the stage of granulosa cell function. Immature granulosa cells cultured in defined medium exhibit little or no immunoreactive Sgk (27) . When these cells are exposed to FSH for 2 h, sgk is induced and is localized to granulosa cell nuclei (27) . In contrast, as granulosa cells differentiate in culture in response to FSH/T, Sgk becomes exclusively localized to a perinuclear region of the cytoplasm (27) . In a similar manner, Sgk protein was localized to nuclei of mammary epithelial cells during S and G2/M phases of the cell cycle, but was cytoplasmic during the G 1 transition or in cells arrested in G 1 as a consequence of hormone stimulation (28) . These intriguing observations in ovarian granulosa cells and mammary tumor cells indicate that Sgk may have dual functions relating to cell cycle progression vs. terminal differentiation when cells exit from the cell cycle (27, 28) . Recent results have also determined that Sgk is a substrate for and can be activated by 3-phosphoinositide-dependent kinase, PDK1 (29) . PDK1 phosphorylates threonine 256 in the activation loop of Sgk, a position similar to that of other kinases phosphorylated by PDK1, such as PKB␣, p70 s6k , protein kinase C, and A-kinase (29) . This places Sgk in a kinase cascade downstream of the PDK1, PI 3-kinase, and growth factor stimulation. Although specific substrates for Sgk are not yet known, some preferred targets have been identified using a synthetic peptide screening assay (29) . That the ovarian cells contain an abundance of Sgk, that it is hormonally regulated and differentially localized to the nucleus or cytoplasm indicates that it is likely to have more than one specific function in this tissue.
The forgoing studies have all been performed using primary cultures of rat ovarian cells (26, 27) or cell lines (20, 21, 28, 29) in which the direct and specific effects of hormones and other agonists on mRNA, protein, and promoter activity could be analyzed. Culture systems often, but not always, mimic events occurring within a physiological context. Therefore, in this study we sought to determine whether the pattern of sgk expression (mRNA and protein) as well as the subcellular localization of Sgk protein were hormonally regulated and dependent on the stage of follicular development and luteinization. Two in vivo model systems were used: a hypophysectomized rat system in which the effects of individual hormones could be assessed at specific developmental stages (30 -32) , and pregnant rats in which corpora lutea (CL) are fully functional (16, 19) . In each system, the expression of sgk was analyzed by in situ hybridization, Northern and Western blotting, and immunohistochemistry. The collective advantages afforded by each of these models and approaches provide a detailed representation of the in vivo pattern of sgk expression.
Materials and Methods Animals
Animals were treated in accordance with the principles and procedures outlined in Guidelines for Care and Use of Experimental Animals.
Hypophysectomized rats. Female Holtzman Sprague Dawley (Harlan, Indianapolis, IN) rats were hypophysectomized (H) on day 26 of age and were either left untreated or were injected once daily for 3 days with estradiol (E; 1.5 mg/0.2 ml propylene glycol; HE) to stimulate the growth of large preantral follicles. Some HE rats were additionally treated twice daily for up to 2 days with sc injections of FSH (1.0 g/0.1 ml PBS; HEF) to stimulate the development of preovulatory follicles. The HEF rats were injected with an ip injection of 10 IU hCG to stimulate ovulation and luteinization. Twenty-four hours later, half the rats were left untreated; half were injected with PRL (10 g in 0.2 ml PBS-10% polyvinyl pyrrolidone PBS-10% PVP twice daily for 2 days). Ovaries were harvested at the designated times (HEF/hCG plus PRL). The effects of E, FSH, and LH on ovarian cell gene expression in this model system have been well characterized (1, 2, 30, 31) . In selected experiments, FSH (10 g/0.1 ml PBS) was administered iv to H rats or HE rats, and E (1 mg/0.1 ml, iv) was administered to H rats to analyze the acute effects of these hormones on Sgk protein. In each experiment, ovaries were isolated for in situ hybridization as well as for preparation of RNA or protein.
Pregnant rats. Timed pregnant rats (Harlan Sprague Dawley, Inc., Indianapolis, IN) were obtained on day 4 of gestation (the day of sperm positive was designated day 1). Corpora lutea and residual ovarian tissue (containing follicles and interstitial tissue) were isolated from ovaries on the designated days of gestation. The tissues were fixed for in situ hybridization, snap-frozen in liquid nitrogen for RNA or whole cell extracts (WCE) or homogenized in boiling SDS buffer (as described below) for total cell protein extracts.
In situ hybridization
Ovaries from hormonally primed H rats and pregnant rats were fixed immediately in 4% paraformaldehyde in PBS overnight at 4 C before dehydration and paraffin embedding. Sections (6 m) were baked at 42 C overnight onto 3-amino-propyltriethoxysilane-coated slides. Slides were prehybridized, hybridized, washed, exposed, and developed as previously described (10, 33) . The 35 S-labeled riboprobes were also produced as previously described (10, 33) . Sgk sense and antisense probes were produced by transcription from the T3 and T7 promoters, respectively, on the NheI-digested pBS-sgk vector. Each slide was incubated in 80 l hybridization solution containing 5 million counts of the appropriate probe overnight at 55 C in a humid chamber. After washing, slides were exposed to X-OMAT-AR film to determine the approximate NTB-2 emulsion exposure time. For most experiments, a 3-day exposure was sufficient. For each in situ hybridization analysis, slides containing ovaries in each treatment group were included to permit direct comparisons of the relative amount of sgk mRNA signal during follicular development and luteinization.
RNA isolation and Northern analysis
RNA was isolated (34) from granulosa cells of H rats using a RNA extraction buffer [140 mm NaCl, 5 mm KCl, 3 mm MgCl 2 , 25 mm Tris-HCl (pH 7.5), and 1% Nonidet P-40] at 4 C followed by centrifugation, phenol extraction in the presence of 1% SDS, and two subsequent extractions with phenol/chloroform (1:1) and chloroform. RNA was ethanol precipitated and resuspended in water previously treated with diethyl pyrocarbonate and quantified by OD at 260 nm.
RNA was isolated from CL and residual tissue of HEF-hCG rats and pregnant rats using a guanidine-isothiocyanate method (19) . For Northern analysis, RNA samples (20 g) were resuspended in 45% formamide-5.4% formaldehyde and denatured at 55 C for 15 min. After the addition of 4 ϫ RNA tracking dye (50 mm HEPES, 50% glycerol, and 0.25% bromophenol blue), RNA was resolved by electrophoresis in 18% formaldehyde-1.2% agarose gels at room temperature. Acridine orange (10 mg/ml) staining allowed assessment of RNA ladder migration and confirmation of equal sample loading by the UV intensity of 28S and 18S ribosomal RNA bands. After the RNA was transferred to a nylon membrane in 20 ϫ SSC (standard saline citrate), the blot was baked for 1 h at 80 C, prehybridized, and hybridized under standard conditions with 1 ϫ 10 6 cpm/ml sgk complementary DNA (cDNA) probe labeled as previously described using random primers and [␣-
32 P]deoxy-CTP (35) . Blots were washed according to ICN specifications (ICN Pharmaceuticals, Inc., Costa Mesa, CA) and exposed to x-ray film at Ϫ70 C. Results were quantified using a Betascope analyzer (Betagen Corp., Mountain View, CA).
Protein preparation and Western analysis
Protein was isolated from granulosa cells and luteal cells by homogenization in WCE buffer (10 mm Tris, 1 mm EDTA, 1 mm DTT, 400 mm KCl, 10% glycerol, 1 mm PMSF, 1 mm vanadate, 1 mm diethyldithiocarbamic acid, and 0.1 mg/ml aprotinin) followed by centrifugation (1 min in microfuge) to isolate soluble protein (18, 36) . The concentrations of soluble protein in each sample were determined by Bradford assay (reagents from Bio-Rad Laboratories, Inc., Hercules, CA). Western blots were run using 30 g WCE protein.
One-dimensional SDS-PAGE with 4.5% stacking and 10% separating acrylamide gels was used to resolve proteins. Proteins were electrophoretically transferred to 0.45-mm Immobilon membranes and blocked for 1 h in PBS containing 5% milk and 0.1% Tween-20. After one 20-min incubation in wash solution (1% milk in PBS and 0.1% Tween-20), filters were incubated for 1 h with appropriate dilutions of Sgk antibody (1:7500) (27) or Sp1 (1:500; Santa Cruz Biotechnology, Inc., Santa Cruz, CA). After three washes (10 min each), blots were incubated with 1:5000 antirabbit horseradish peroxidase, washed as before, and detected using the enhanced chemiluminescence assay system ECL (Amersham Pharmacia Biotech, Arlington Heights, IL). Immunoreactive signals were analyzed and quantified using an AlphaImager 2000 (3.3, Alpha Innotech Corp., San Leandro, CA)
Immunohistochemical analyses
The cellular and subcellular localizations of Sgk and Sp1 were analyzed by immunostaining 4% paraformaldehyde-fixed and paraffinembedded ovaries as described for in situ hybridization. Sections (6 m) were processed according to routine procedures. Briefly, rehydrated sections were boiled in 0.1% hydrogen peroxide followed by PBS washes. Sections were then incubated with 10% nonimmune goat serum to block nonspecific sites followed by incubation with affinity-purified Sgk antiserum (27, 28) or Sp1 antiserum (Santa Cruz Biotechnology, Inc.) diluted 1:50 in 10% goat serum overnight at room temperature. After washing in PBS, biotinylated antirabbit antiserum (Vector, Burlingame, CA) was added for 30 min, slides were washed, and streptavidin-conjugated horseradish peroxidase was applied for 30 min. Sections were incubated with diaminobenzidene substrate for 2 min, dehydrated without counterstaining, and mounted.
Statistical analyses
Where indicated, statistical analyses were performed by ANOVA. Values represent the mean Ϯ sem for at least three separate experiments and were considered significantly different if P Ͻ 0.05.
Results

Hormonally regulated expression of sgk mRNA during follicular development and luteinization
In situ hybridization. To determine whether sgk mRNA expression was regulated during follicular development, a hormone-stimulated hypophysectomized rat model was used (30, 31) . Because these rats lack endogenous gonadotropins, follicular maturation occurs only upon the exogenous administration of steroids, FSH, and LH. Before hormone treatment (H), the ovary contains small follicles arrested at var-FIG. 1. Localization of sgk mRNA expression during follicular development and luteinization. Localization of sgk mRNA during follicular development and luteinization was analyzed by in situ hybridization of ovaries from hormone-stimulated hypophysectomized (H) rats. H rats were either untreated or were administered E for 3 days (HE) or E followed by FSH (10 g/0.1 ml, iv) for 2 h (HEF 2h), 4 h (not shown), or 8 h (HEF 8h) to analyze the acute effects of FSH and increased intracellular cAMP on sgk expression. Other HE rats were treated with FSH (1 g/0.1 ml, sc, twice daily for 2 days) for 48 h (HEF 48h) to stimulate the development of preovulatory follicles. HEF (48 h) rats were treated with 10 IU hCG to stimulate ovulation and luteinization. The sgk mRNA was analyzed using a radiolabeled antisense sgk riboprobe. To confirm the specificity of the sgk signal, an sgk sense probe was used on the HEF/hCG, 48 h sample. Both light-and darkfield micrographs are shown for the same tissue section to enable visualization of sgk localization in the context of ovarian histology. These are representative of three different experiments in which the results were highly reproducible.
ious stages of growth (Fig. 1) . Stimulation with estradiol (E) for 3 days results in granulosa cell proliferation (10, 11, 30) and growth of preantral follicles (HE) (31) . Intravenous injections of FSH (1 g) were given to HE rats to rapidly increase granulosa cell production of cAMP (37) and to examine the immediate early expression of sgk mRNA. As shown, FSH did not markedly change the histological appearance of the HE ovaries (Fig. 1, HE, FSH, 2 and 8 h) . However, sc injections of FSH (1 g twice daily for 2 days) stimulated the growth of large antral, preovulatory follicles (HEF, 48 h), at which time injection with hCG can cause ovulation and the subsequent formation of CL (HEF/hCG).
In situ hybridization of ovaries at each of these stages enabled the examination of sgk expression throughout follicular development as well as in response to bolus injections of FSH and hCG. In the ovaries of H rats, sgk mRNA was negligible in granulosa cells of small follicles, but was detected in the interstitial compartment surrounding the follicles. (Fig. 1, H) . In ovaries of HE rats, Sgk mRNA remained low in granulosa cells of growing preantral follicles and was markedly reduced in the interstitial cells (Fig. 1, HE) . Sgk mRNA was induced in granulosa cells within 2 h after a single iv injection of FSH, and the intensity of the sgk signal increased further at 8 h (Fig. 1 , FSH, 2 and 8 h). The sgk mRNA was also induced in granulosa cells of HE rats after a regimen of FSH treatment that stimulates the development of preovulatory follicles (Fig. 1, HEF, 48 h ). In these preovulatory follicles sgk exhibits a gradient pattern, with highest levels in the most differentiated, least proliferative, mural granulosa cells (Fig. 1, HEF, 48 h) . Corpora lutea isolated 48 h after a bolus injection of hCG also expressed high levels of Sgk mRNA (Fig. 1 , HEF/hCG, 48 h). Hybridization with the sense Sgk cDNA as a control showed no signal (Fig. 1 , HEF/ hCG, sense). The rapid induction of sgk mRNA by FSH in proliferating granulosa cells as well as its expression in the more differentiated, mural granulosa cells and luteal cells suggest that Sgk may regulate specific targets in proliferating vs. differentiating granulosa cells.
To further examine the regulation of sgk expression in the CL, ovaries from HEF rats that had been stimulated with an ovulatory dose of hCG for 4, 12, 24, and 48 h were isolated for in situ hybridization. The sgk mRNA was readily apparent in granulosa cells of preovulatory follicles (Fig. 2 . HEF, 48 h; also see Fig. 1 ). Four hours after injection of hCG, sgk mRNA expression was reduced in the ovulatory follicle (Fig. 2 , HEF hCG, 4 h). However, within 12 h, sgk mRNA was again increased in the ovulatory follicle (not shown), and by 24 -48 h of hCG stimulation, sgk mRNA levels were markedly elevated in cells of the newly formed CL.
Northern blot. These in situ hybridization data concur with results obtained by Northern blot analyses of RNA isolated from the ovarian tissues. Specifically, sgk mRNA was low in granulosa cells prepared from small follicles of H rats before and after treatment with E. However, sgk mRNA was elevated in granulosa cells of preovulatory follicles of HEF rats (Fig. 3 ). An ovulatory dose of hCG caused sgk mRNA levels to decline by 2 h and remain low at 8 h. However, in association with the formation of the CL at 24 -48 h after hCG, sgk mRNA increased dramatically. Thus, the highest levels of sgk mRNA are present in granulosa cells that have terminally differentiated into nondividing luteal cells.
Western blots. Changes in the amount of Sgk protein exhibit a pattern similar to that for sgk mRNA. Specifically, the level of Sgk protein is low in granulosa cells isolated from ovaries of H rats (Fig. 4A, H ). E treatment for 3 days had little or no effect (Fig. 4A, HE) . However, a single iv injection of FSH stimulated a rapid, 7-fold increase in Sgk protein at 2 h, which remained elevated at 4 and 8 h ( Fig. 4A; FSH, 2, 4 , and 8 h). Similarly, two sc injections of FSH stimulated a 7.9-fold increase in Sgk protein at 24 h (Fig. 4A, HEF, 24 h ). In these same samples, the levels of Sp1 (38), a transcription factor that regulates sgk expression in granulosa cells (26), were
Localization of sgk mRNA expression in developing CL. HEF, 48 h rats were administered hCG (10 IU/0.2 ml, iv), after which ovaries were isolated at the indicated times. Localization of sgk expression during early stages of luteal development was analyzed in these ovaries by in situ hybridization with a radiolabeled sgk riboprobe. Darkfield images show sgk localization to preovulatory follicles and CL. These data are representative of three separate experiments.
FIG. 3.
Regulation of sgk mRNA expression during follicular and luteal development. Hypophysectomized rats were left untreated (H) or were administered estradiol (HE) or estradiol followed by FSH for 48 h (HEF 48h). Some HEF rats were then administered hCG, after which ovaries were isolated at the indicated times. Total RNA was isolated from ovaries of hormone-treated rats and examined by Northern analysis with a radiolabeled sgk cDNA probe. The sgk mRNA increased 8-to 11-fold in granulosa cells of HEF compared with HE rats, decreased 2-to 3-fold at 2-8 h after hCG, and then increased in luteal cells collected at 24 and 48 h post-hCG to levels 5Ϯ 0.5-fold higher than those in granulosa cells of HEF rats, resulting in approximately 30-to 40-fold overall induction from the levels observed in H and HE granulosa cells. Highly similar results were observed in three separate experiments.
high and remained unchanged by hormone treatment (Fig.  4A) .
The highest levels of Sgk protein were observed in CL (Fig.  4B) . In this experiment, changes in the expression of Sgk during follicular growth were compared with that following hCG-induced luteinization. As described above, the level of Sgk was low in granulosa cells of H rats and was increased 1.3-fold by E, 8.2-fold by acute FSH stimulation at 2 h (HEF, 2 h), and 17-fold by sc injections of FSH for 48 h (HEF, 48 h ). An iv injection of hCG (10 IU) stimulated only a slight increase in Sgk protein at 2 h (HEF/hCG, 2 h) which was decreased 25% at 4 h. Sgk protein then increased progressively at 12, 24, and 48 h after hCG to achieve levels 22-, 28-, and 35-fold greater than those in granulosa cells of H rats. When levels of Sp1 were examined in these same samples, Sp1 remained essentially unchanged, with the exception of a decrease 48 h after hCG (Fig. 4B) .
In many samples, there are multiple immunoreactive Sgk bands. As Sgk has recently been shown to be a phosphoprotein (29) , and the phosphorylation of specific sites is requisite for its own kinase activity (29) the slower migrating, immunoreactive bands are presumed to represent phosphorylated states of Sgk. Note in particular the three bands in the HEF, 2 h sample (Fig. 4B ) and in the HEF/hCG samples (Fig.  4B) . Note also what appear to be smaller bands in the HEF/ hCG 24 and 48 h samples (Fig. 4B) . These may represent partially degraded forms of Sgk. Whatever their identity, they represent a small proportion of the total immunoreactive material.
To determine whether the induction and expression of Sgk protein in response to the acute iv injection of FSH were dependent on the exposure of granulosa cells to E, additional experiments were performed in which either FSH (10 g) or E (1 mg) was injected iv to H rats. As shown in Fig. 5 , Sgk was low in granulosa cells of H rats. Exposure to FSH caused a rapid, 7.6-fold increase in Sgk protein (Fig. 5) , a response similar to that observed when HE rats were stimulated with a similar dose of FSH (Fig. 4, A and B ; HEF, 2 h). However, in the H rats the levels of Sgk protein in granulosa cells declined 50% by 12 h. Note also that there were multiple immunoreactive bands present in the H/FSH, 2 h sample, some of which appeared to be phospho-Sgk, whereas others appeared to be smaller, degraded fragments (Fig. 5) . These data also show that E can evoke a rapid, 3.7-fold increase in Sgk protein at 2 h that does not exhibit lower mol wt forms (Fig. 5) . However, the effect of E is not sustained, and the levels of Sgk protein in granulosa cells return to those in the H rats by 24 h (Fig. 5 ) as observed after 3 days of E treatment (Fig. 4) . Thus, although the rapid induction of Sgk protein by FSH does not require prior exposure of granulosa cells to E, E-mediated differentiation of granulosa cells appears to facilitate and prolong Sgk expression in granulosa cells.
Sgk expression in ovaries of pregnant rats
To further analyze the expression of sgk mRNA and protein in functional CL, we selected the pregnant rat as a phys -FIG. 4 . Induction of Sgk protein during follicular growth and differentiation. Granulosa cells and CL were isolated from hormonally primed H rats (as described in Fig. 1 ) and homogenized in WCE buffer. Protein samples (50 g) from each treatment group were analyzed by SDS-PAGE followed by ECL detection of Sgk and Sp1 protein using specific antibodies and quantified by phosphorimaging. Sp1 was selected as an internal control, as we have shown previously that it is not hormonally regulated (26) , and it is important for transcriptional regulation of the sgk gene in granulosa cells (26) iological model in which CL are maintained by endogenous hormones. In situ hybridization analyses showed that sgk mRNA was expressed in functional CL present from 7-22 days of pregnancy (Fig. 6) . Interestingly, the interstitial tissue of ovaries collected on days 7, 15, and 22 of gestation also exhibited significant levels of sgk mRNA. These in situ hybridization data indicate that sgk expression is maintained in luteal cells throughout pregnancy as well as in cells present in the interstitial compartment.
Northern analysis of RNA prepared from isolated CL and residual (follicles and interstitium) tissue confirmed expression of sgk mRNA in each ovarian compartment during pregnancy (Fig. 7) . Sgk mRNA was present in the mature, functional CL on days 7 and 15 of gestation as well as on day 21, a time when luteal cells begin to undergo regression. Levels of sgk mRNA in the residual compartment of pregnant rat ovaries on days 7, 15, and 21 of gestation were similar to those observed in luteal cells on these same days.
Sgk protein levels in the pregnant CL were similar to those observed in luteal tissue of the HEF/hCG-treated rats (ratio, 1.0; HEF/hCG day 7 CL; Fig. 8 ). Sgk protein remained elevated on days 13 (not shown), 15, and 22 of gestation and had decreased 25% in CL obtained 1 day postpartum (Fig. 8) .
Despite the high levels of sgk mRNA in the residual ovarian component (Fig. 7) , Sgk protein in this tissue was lower than that in the luteal cells (Fig. 8) . For example, the ratios of Sgk protein in the CL compared with residual tissue on days 7, 15, and 22 of gestation and postpartum day 1 were 4.9-, 4.0-, 1.8-, and 7.3-fold, respectively. Thus, the only time during gestation when the residual tissue approximated that of the luteal cells was on day 22, a time when the level in luteal cells declined and that in the residual tissue had increased (i.e. in day 22 residual tissue, Sgk was 2-fold higher than that on day 7). Levels of Sgk in the ovary of a nonpregnant rat were similar to those of CL in the postpartum rat (not shown). There seems to be no easy explanation to account for why there is less Sgk protein in the residual compartment than would be predicted based on the in situ hybridization data and Northern blot results. The apparent discrepancy is not related to the method of extraction, as similar results were obtained when proteins were prepared in boiling SDS buffer (data not shown). It is possible that Sgk protein is less stable than the mRNA in the interstitial cells. However, we did not observe any increase in lower mol wt immunoreactive bands. The transcriptional regulation of the sgk gene is complex, and virtually nothing is known for the interstitial cells. Likewise, it is becoming clear that the functional roles of Sgk as well as its activation are complex. When more is known about this kinase, the answer may be forthcoming.
Regulation of sgk mRNA and protein by PRL in luteal cells and residual tissue
Because PRL is the major luteotropic hormone in the rat and because the level of sgk expression was elevated in luteal tissue, we next sought to determine whether the expression of Sgk protein in luteal cells and residual tissue could be regulated by PRL. For this study, HEF rats with ovaries containing preovulatory follicles or HEF-hCG-primed rats with ovaries containing CL were treated with PRL in vivo for 24 h. As shown by Western blot analyses (Fig. 9) , Sgk protein was present in granulosa cells of preovulatory follicles (HEF) but decreased slightly (20%) after exposure to PRL (1 g/0.1 ml, iv) alone for 24 h. In contrast, levels of Sgk protein increased (3-fold) in CL of HEF-hCG-treated rats and were further elevated (1.6-fold) by exposure to PRL for 24 h. Residual tissue exhibited a similar response; Sgk protein increased (1.7-fold) in response to PRL in the HEF-hCG-treated ovaries, but not in the HEF ovaries. In situ hybridization (not FIG. 6 . Localization of sgk mRNA expression in pregnant rat ovaries. Ovaries were isolated from timed pregnant rats on the indicated days of pregnancy and analyzed by in situ hybridization as described in Fig.  1 . Use of a sense sgk riboprobe confirms the specificity of the sgk signal. The sgk mRNA was expressed in both the CL and in the interstitial compartment of pregnant rat ovaries. In addition, WCE of CL from HEF/hCG-treated rats were prepared (see Fig. 4B ). For each sample, 50 g protein were loaded. Western analysis was performed using an affinity-purified polyclonal Sgk antibody, followed by ECL detection. The upper and lower panels represent data collected from one experiment but at different exposure times (16 h and 5 min, respectively). The data in the lower panel were used to quantify by image analyses the differences in immunoreactive Sgk levels seen in each tissue sample. The data are representative of two separate, highly reproducible experiments.
shown), confirmed that sgk mRNA was elevated in CL of HEF-hCG (24-h)-treated rats exposed to PRL for 6 and 24 h. Thus, during the LH-induced luteinization process, sgk expression is increased, and PRL further modulates the levels of sgk mRNA and protein approximately 1.5-fold.
Subcellular localization of Sgk and Sp1/Sp3 in granulosa cells and luteal cells
Previous studies using granulosa and mammary cell culture systems indicated that the subcellular localization of Sgk protein is hormonally regulated (27, 28) and possibly cell cycle dependent (28) . Therefore, immunohistochemical studies were performed to determine the cellular and subcellular localization of Sgk protein in intact ovaries containing follicles and CL at specific stages of development. As shown in Fig. 10 (A-C) , immunoreactive Sgk was detected in large antral follicles (Fig. 10A ) with localization to both the granulosa cells (Fig. 10B, asterisk) as well as to specific cells within the thecal layer (arrows). In the proliferative, but differentiating, granulosa cells, immunostaining was varied among cells, but was localized predominantly to the nuclear compartment (Fig. 10B, stained cell next to the asterisk) . Likewise, Sgk appeared nuclear in the immunopositive cells within the thecal layer (Fig. 10C) . Although these Sgk-immunopositive cells appear to be thecal endocrine cells, it is also possible that they represent proliferating fibroblasts or immune cells. Intense immunostaining of Sgk was also detected in the oocytes of primordial follicles (Fig. 10, D and E, arrows) residing beneath the surface epithelium. In these primordial oocytes, immunoreactive Sgk was localized primarily to a perinuclear region of the cell. In contrast, immunoreactive Sgk was low or absent in the oocytes, granulosa cells, and thecal cells of small growing follicles, but was present in adjacent interstitial cells, where it was localized to the cytoplasm (Fig. 10F) . Intense immunostaining of Sgk protein was also observed in CL of pregnant rats, where it was localized to a perinuclear region of the cytoplasm (Fig. 10, G and H, arrows) . Sgk protein was also present at high levels in certain clusters of cells within the interstitial compartment of the pregnant rat ovary. In these clusters of interstitial cells, as in the luteal cells, Sgk was localized to the cytoplasmic region of the cells, not the nucleus. Although the identification of the cells within the interstitial region is not yet known, their size and morphology indicate that they may be part of the steroidogenic component of the interstitium. No immunostaining was observed in the absence of the primary Sgk antibody (Fig. 10I) . The transcription factor, Sp1 (and Sp3, not shown), which is known to regulate Sgk expression in ovarian cells was localized exclusively to the nuclei of granulosa, thecal, luteal, and interstitial cells (Fig. 10, J-L) . Collectively, these data indicate that the subcellular localization of Sgk is dependent on the stage of granulosa and luteal cell differentiation, whereas Sp1 is always nuclear.
Discussion
The results of this study document that the expression of sgk mRNA and the subcellular localization of Sgk protein in granulosa cells are hormonally regulated in vivo throughout follicular development and luteinization. Notably, these studies provide the first documentation in vivo in any tissue that sgk expression and its subcellular localization are related to tissue growth and differentiation. Not only does sgk exhibit a pattern of induction in granulosa cells consistent with an immediate early gene, but it also appears to be constitutively expressed in terminally differentiated luteal cells. The dramatic switch in the subcellular localization of Sgk protein suggests that it controls specific functions in proliferative granulosa cells compared with terminally differentiated luteal cells.
Induction of sgk by FSH in granulosa cells is rapid, a pattern consistent with immediate early induction of this gene in other cells that respond to agonists such as serum and glucocorticoids (20, 21) , brain injury (22) , and cAMP (Ref. 26 and present study). The induction of sgk mRNA in granulosa cells is also associated with specific stages of granulosa cell proliferation. The level of sgk mRNA was low (Northern blot) or undetected (in situ hybridization) in granulosa cells of preantral follicles where the cells are proliferating at an extremely slow rate (H rat) (30, 32) . Treatment of H rats with E markedly increased granulosa cell proliferation, as indicated by previous studies in which tritiated thymidine labeling was used to determine the labeling index (30) as well as by more recent studies in which the induction of the cell cycle activator, cyclin D2, has been analyzed (10, 11) . Despite the marked effect of E on granulosa cell proliferation, sgk mRNA after 3 days of E treatment was only marginally affected by this steroid as indicated by both in situ hybridization and Northern blot analyses. However, when short time intervals were analyzed, the results show that E alone can increase Sgk within 2 h. However, the most dramatic increases in sgk expression were induced by FSH in granulosa cells of H rats or HE rats, where a 7-to 8-fold induction FIG. 9 . PRL regulation of Sgk protein in granulosa and luteal cells of HEF-and HEF-hCG-treated rats. Granulosa cells were isolated from preovulatory ovaries of HEF-treated rats, CL were dissected from ovaries of HEF rats treated with hCG for 24 h, and the remaining residual ovarian tissue was saved. In each treatment group, half of the rats were injected with 10 g PRL/0.2 ml PBS-10% PVP 24 h before sacrifice. WCE were prepared, and 50 g protein were analyzed for each sample by Western blotting with an affinity-purified polyclonal Sgk antibody followed by detection with ECL and phosphorimaging. where it localized to granulosa cells (B, asterisk) and specific thecal cells (C, arrow). Sgk protein was localized to nuclei of the immunopositive granulosa cells and thecal cells. Sgk protein was also observed in oocytes of primordial follicles residing under the surface epithelium (D, arrow; magnification, ϫ10). In these oocytes, the staining appeared to be mostly cytoplasmic (E; magnification, ϫ40). Less staining was observed in the oocyte of a small primary follicle (F; magnification, ϫ40). In this same section (F), positive staining for Sgk was observed to the cytoplasmic was seen within 2 h. The rapid induction of sgk expression by FSH in the HE rats coincides temporally with a secondary burst of proliferative activity that occurs in granulosa cells of large preantral follicles as they become preovulatory follicles (30) . Both the labeling index (30) as well as the expression of cyclin D2 (10, 11) are increased by FSH in granulosa cells of HE rats. These results indicate that in the ovary, sgk expression is associated with but not strictly related to all stages of granulosa cell proliferation. Rather, sgk expression is stimulated in these cells by FSH/cAMP and, in this way, may synergize with events stimulated by other factors, such as E. These results in vivo are similar to the biphasic induction of sgk mRNA and protein observed throughout differentiation of immature primary cell cultures to the preovulatory phenotype (26, 27) .
FSH initiates a cascade of cellular and biochemical signals in granulosa cells that leads to changes in the way the cells respond to those signals. For example, although Sgk, as well as specific kinases (cdks) controlling progression through the cell cycle are immediate targets of FSH action (10, 11, 26, 27) , extended exposure of cells to FSH is required for the expression of other genes, including aromatase (resulting in elevated levels of estradiol) (1), the LH receptor (3), and ␣ inhibin (39) . Collectively, these events and other cellular changes produce a differentiated granulosa cell phenotype. The secondary induction of sgk after prolonged FSH exposure, therefore, appears more a result of the unique differentiated state than a direct response to a singular rapid effect of FSH. Within a preovulatory follicle, the granulosa cells comprise a heterogeneous population, because the progression of granulosa cell differentiation through the follicle occurs in a gradient pattern. Granulosa cells adjacent to the antrum of the follicle are still proliferative at this time (10, 11, 32) . However, the mural granulosa cells adjacent to the basement membrane are less mitotic and are the first to express markers of granulosa cell differentiation such as the LH receptor (40, 41) . Reflecting the relationship between the differentiated state and sgk expression is the observation that sgk mRNA is also expressed in a gradient in the preovulatory follicle, with the highest levels seen in the most differentiated mural granulosa cells.
The LH surge rapidly initiates the terminal differentiation of granulosa cells to luteal cells. Beginning within 4 h and complete by 12 h of exposure to LH, granulosa cells cease to divide, as indicated by the absence of cells showing positive staining for bromodeoxyuridine (11) . The cessation of cell division is associated with the rapid loss of cyclin D2 and the increased expression of cell cycle inhibitors, p21 CIP1 and p27 KIP1 (10, 11) . During this time, granulosa cells are completely reprogrammed to become luteal cells (42, 43) . They acquire and maintain a stable luteal cell phenotype in vivo and in vitro, as characterized by the constitutively elevated expression of genes such as cholesterol side-chain cleavage cytochrome P450, P450scc, even in the absence of FSH and LH (42, 43) . Although sgk expression is rapidly reduced by the LH surge, this decrease is transient. The expressions of sgk mRNA and protein are increased as the cells begin to luteinize (within 12 h post-hCG) in vivo (results herein) and as we have recently shown in vitro (27) . The levels continue to rise as the mature CL is formed (24 -48 h post-hCG) until they reach maximal levels during midgestation (day 15 of pregnancy). At this time the CL also express maximal levels of mRNA encoding other proteins (15): P450scc (44), aromatase (45), LH receptor (3), ␣ 2 -macroglobulin (19, 46) , and relaxin (47) . During pregnancy the expression of genes encoding these proteins is regulated principally by the sequential action of pituitary PRL and rat placental lactogens in conjunction with steroid hormones and other factors. Therefore, maximal sgk expression concurs with highest levels of steroidogenic activity and PRL/rat placental lactogen secretion.
Because of the enhanced expression of sgk mRNA and protein in the CL as well as the known luteotropic actions of PRL/rPL on regulating gene expression in luteal cells (16 -19) , we sought to determine whether PRL might induce or regulate sgk expression. As shown herein, PRL did not markedly alter Sgk expression in preovulatory granulosa cells. This was not unexpected, as most of the known effects of PRL in the rat ovary are mediated at the level of the CL or interstitial cells. In this regard, PRL augmented, but did not induce, the elevated expression of sgk in luteal cells. This pattern of expression is similar to that of P450scc, which is modulated, but not induced, by PRL (45) . In contrast, PRL activation of the Jak/Stat signaling pathway is obligatory for luteal cell expression of ␣ 2 -microglobulin (17) (18) (19) . Thus, sgk, like many, but not all, genes in the ovary, is a PRL-regulated, but not PRL-inducible, gene.
The presence of Sgk protein in oocytes of primordial follicles indicates that Sgk has a function in the female germ cell as well as in somatic cells. As oocytes in primordial follicles are arrested in meiotic prophase, Sgk may be critical for ensuring arrest at this specific stage of the meiotic process. However, in growing follicles in which the oocytes have resumed or completed growth (but not meiosis), the level of Sgk protein was low or absent, indicating that Sgk may exert functions in oocytes of primordial follicles in addition to or other than meiotic arrest.
The expression of sgk in proliferating granulosa cells as well as in terminally differentiated luteal cells and resting oocytes suggests that Sgk may have multiple functions in controlling cell cycle progression and differentiation. This hypothesis is supported by the observations herein, which show that Sgk protein localizes to nuclei of granulosa cells but is clearly cytoplasmic and largely excluded from nuclei of luteal cells and oocytes. These results in vivo support and extend our recent observations in granulosa and luteal cells in culture (27) as well as studies of the expression and localization of Sgk during the cell cycle in mammary epithelial compartment of interstitial cells (I), whereas negligible staining was observed in granulosa cells (gc) or thecal cells (tc). Intense immunostaining of Sgk protein was observed in CL of pregnant rats (G, arrows; magnification, ϫ10), where it localized to a perinuclear region within the cytoplasm of the luteal cells (H, arrows; magnification, ϫ40). No immunopositive staining was observed in the absence of primary antibody in this section of luteal cells (I; magnification, ϫ40) or other sections containing follicles (not shown). The transcription factor, Sp1, was nuclear in cells of the corpus luteum (cl), the interstitium (I), thecal cells (tc), and granulosa cells (gc; J-L; magnification, ϫ40).
tumor cells (28) . Nuclear import and export mechanisms are complex and involve many different control mechanisms (48 -52) . As Sgk protein contains both a putative nuclear localization signals (NLS) as well as a putative nuclear export signal (NES), the subcellular distribution of Sgk may be regulated by the changes in functional activity (phosphorylation?) of either one or both of these trafficking signals. Recent observations indicate that Sgk is a phosphoprotein and thus is probably a specific substrate of a specific cellular kinase cascade(s) (29) . Cytoplasmic localization could indicate that function of the NLS is blocked, whereas the NES is active. Conversely, nuclear localization may occur when NLS, but not NES, is active. Anchoring of Sgk to specific docking sites (27, 28) may also occur in a fashion analogous to that in other kinases (53, 54) . As Sgk is a kinase, it is tempting to speculate that restriction of Sgk to the nucleus in proliferating granulosa cells allows specific nuclear substrates to be phosphorylated, whereas exclusion of Sgk from the nucleus in luteal cells favors phosphorylation of cytoplasmic substrates that maintain a terminally differentiated state of luteal cells or the arrested state within oocytes.
In summary, these studies in vivo provide the first evidence that Sgk is expressed in several ovarian cell types, including the oocytes of primordial follicles, and that Sgk exhibits distinct subcellular localization depending on the hormonal stimulation and the stage of cell differentiation.
